News
Lawmakers warn the arrangement Eli Lilly and Pfizer have with telehealth platforms may lead to conflicts of interest, subpar ...
Partnerships between telehealth companies and pharmaceutical giants Pfizer and Eli Lilly raise concerns about conflicts of interest and inappropriate prescribing, according to a Senate investigation ...
The opportunity to “ talk to a doctor now ” increases access to care, the drug companies say. But the legislators, and some ...
A High Rate of Prescriptions Are Written. The Report examined the number of prescriptions that resulted from patient participation in a Program, concluding that the rate was “high”. In one case, the ...
14d
MedPage Today on MSNMRI Leaves Man in Critical Condition; Dexcom Recall After 56 Injuries; Drug Denials
Note that some links may require registration or subscription. A New York man who entered an MRI room while a scan was taking ...
The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...
In April 2025, Eli Lilly and Company (Lilly) filed lawsuits in the U.S. District Court for the Northern District of California against telehealth companies, alleging the companies sell illegal ...
Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...
Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound An Eli Lilly & Co. Zepbound injection pens. Photographer: Shelby Knowles/Bloomberg By Madison Muller June 10, 2025 at 9:57 AM PDT ...
Eli Lilly will partner only with telehealth firms that agree to stop selling compound versions of its drug Zepbound or Novo Nordisk’s Wegovy, a move that sidelines Hims & Hers Health, Bloomberg ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results